个性化医疗：我们准备好了吗？
Personalised medicine: are we ready?
作者信息
Louis Renaud, Roche Nicolas
机构信息
Dept of Respiratory Medicine, CHU Liege, GIGA I3 Research Group, University of Liege, Liege, Belgium.
Respiratory and Intensive Care Medicine, Cochin Hospital, Hôpitaux Universitaires Paris Centre (APHP) and University Paris Descartes (EA2511), Paris, France
出版信息
Eur Respir Rev. 2017 Sep 27;26(145). doi: 10.1183/16000617.0088-2017. Print 2017 Sep 30.
Abstract
摘要
这看起来是一个网址链接，无法直接翻译为中文。若要翻译，可表述为“http://ow.ly/VGGE30eYTmT（网址链接）” ，但严格来说这不是对内容的翻译，而是对其形式的一种转换说明。如果按要求仅输出中文，可写为“无法翻译，这是一个网址链接：http://ow.ly/VGGE30eYTmT” 。如果仅按照指令直接翻译网址链接里的字符，那就是“欧威利（ow.ly）/VGGE30eYTmT” ，不过这种翻译对于网址来说意义不大，你可根据实际需求进一步明确要求 。
相似文献
1
Personalised medicine: are we ready?个性化医疗：我们准备好了吗？
Eur Respir Rev. 2017 Sep 27;26(145). doi: 10.1183/16000617.0088-2017. Print 2017 Sep 30.
2
Digital Twins: From Personalised Medicine to Precision Public Health.数字孪生：从个性化医疗到精准公共卫生
J Pers Med. 2021 Jul 29;11(8):745. doi: 10.3390/jpm11080745.
3
[Personalised medicine. Paradigm shift within drug research and therapy].[个性化医疗。药物研究与治疗领域的范式转变]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Nov;56(11):1495-501. doi: 10.1007/s00103-013-1820-4.
4
Public perceptions of the risks, benefits and use of natural remedies, pharmaceutical medicines and personalised medicines.公众对天然药物、药物和个体化药物的风险、益处和使用的看法。
Complement Ther Med. 2013 Oct;21(5):487-91. doi: 10.1016/j.ctim.2013.07.007. Epub 2013 Aug 20.
5
Personalised nutrition: ready for practice?个性化营养：准备好付诸实践了吗？
Proc Nutr Soc. 2013 Feb;72(1):48-52. doi: 10.1017/S0029665112002844. Epub 2012 Nov 12.
6
Personalised medicine and the state: A political discourse analysis.个体化医学与国家：政治话语分析。
Health Policy. 2021 Jan;125(1):122-129. doi: 10.1016/j.healthpol.2020.10.005. Epub 2020 Oct 14.
7
Personalised medicine: a critique on the future of health care.个性化医学：对未来医疗保健的批判。
J Bioeth Inq. 2013 Jun;10(2):197-203. doi: 10.1007/s11673-013-9429-8. Epub 2013 Mar 21.
8
The 9th Santorini Conference: Systems Medicine, Personalised Health and Therapy. "The Odyssey from Hope to Practice", Santorini, Greece, 30 September⁻3 October 2018.第九届圣托里尼会议：系统医学、个性化健康与治疗。“从希望到实践的奥德赛之旅”，希腊圣托里尼，2018年9月30日至10月3日。
J Pers Med. 2018 Dec 12;8(4):43. doi: 10.3390/jpm8040043.
9
The Promise and the Hype of 'Personalised Medicine'.“个性化医疗”的前景与炒作
New Bioeth. 2017 Apr;23(1):13-20. doi: 10.1080/20502877.2017.1314886.
10
Personalised medicine in interstitial lung diseases: Number 6 in the Series "Personalised medicine in respiratory diseases" Edited by Renaud Louis and Nicolas Roche.特发性肺纤维化：呼吸疾病个体化医学专辑 6 卷 本 主译：Louis Renaud, Roche Nicolas
Eur Respir Rev. 2018 Apr 13;27(148). doi: 10.1183/16000617.0117-2017. Print 2018 Jun 30.
引用本文的文献
1
Automated Interpretation of Lung Sounds by Deep Learning in Children With Asthma: Scoping Review and Strengths, Weaknesses, Opportunities, and Threats Analysis.深度学习在儿童哮喘肺部声音自动分析中的应用：范围综述及优势、劣势、机会和威胁分析。
J Med Internet Res. 2024 Aug 23;26:e53662. doi: 10.2196/53662.
2
A mixed methods expert opinion study on the optimal content and format for an occupational therapy intervention to improve sleep in schizophrenia spectrum disorders.一项关于职业治疗干预改善精神分裂谱系障碍睡眠的最佳内容和形式的混合方法专家意见研究。
PLoS One. 2022 Jun 6;17(6):e0269453. doi: 10.1371/journal.pone.0269453. eCollection 2022.
3
A systems approach to clinical oncology uses deep phenotyping to deliver personalized care.系统方法在临床肿瘤学中的应用，通过深度表型分析实现个体化医疗。
Nat Rev Clin Oncol. 2020 Mar;17(3):183-194. doi: 10.1038/s41571-019-0273-6. Epub 2019 Oct 16.
4
Are there specific clinical characteristics associated with physician's treatment choices in COPD?在 COPD 中，是否存在与医生治疗选择相关的特定临床特征？
Respir Res. 2019 Aug 20;20(1):189. doi: 10.1186/s12931-019-1156-1.
本文引用的文献
1
Personalised medicine for nonsmall cell lung cancer.非小细胞肺癌的个体化医学。
Eur Respir Rev. 2017 Nov 15;26(146). doi: 10.1183/16000617.0066-2017. Print 2017 Dec 31.
2
Personalised medicine in sleep respiratory disorders: focus on obstructive sleep apnoea diagnosis and treatment.睡眠呼吸障碍的个体化医学：以阻塞性睡眠呼吸暂停的诊断和治疗为重点。
Eur Respir Rev. 2017 Oct 25;26(146). doi: 10.1183/16000617.0069-2017. Print 2017 Dec 31.
3
Personalised medicine in asthma: time for action: Number 1 in the Series "Personalised medicine in respiratory diseases" Edited by Renaud Louis and Nicolas Roche.哮喘的个体化医学：行动的时刻：“呼吸疾病个体化医学”系列第 1 卷，主编 Renaud Louis 和 Nicolas Roche。
Eur Respir Rev. 2017 Sep 27;26(145). doi: 10.1183/16000617.0064-2017. Print 2017 Sep 30.
4
Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial.阿奇霉素对持续性未控制哮喘成人哮喘加重和生活质量的影响（AMAZES）：一项随机、双盲、安慰剂对照试验。
Lancet. 2017 Aug 12;390(10095):659-668. doi: 10.1016/S0140-6736(17)31281-3. Epub 2017 Jul 4.
5
Is it possible to claim or refute sputum eosinophils ≥ 3% in asthmatics with sufficient accuracy using biomarkers?是否有可能使用生物标志物以足够的准确性判定或否定哮喘患者痰液嗜酸性粒细胞≥3%？
Respir Res. 2017 Jul 3;18(1):133. doi: 10.1186/s12931-017-0615-9.
6
Biologics and biomarkers for asthma, urticaria, and nasal polyposis.哮喘、荨麻疹和鼻息肉的生物制剂和生物标志物。
J Allergy Clin Immunol. 2017 May;139(5):1411-1421. doi: 10.1016/j.jaci.2017.03.006.
7
Personomics: A New Series in the Green Journal.《个体经济学：《绿色期刊》的新系列》
Am J Med. 2017 Jun;130(6):622. doi: 10.1016/j.amjmed.2017.01.029. Epub 2017 Feb 16.
8
T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED.在 U-BIOPRED 中使用痰液转录组学研究哮喘的 T 辅助细胞 2（Th2）和非-Th2 分子表型。
Eur Respir J. 2017 Feb 8;49(2). doi: 10.1183/13993003.02135-2016. Print 2017 Feb.
9
Personalised medicine in asthma: from curative to preventive medicine.哮喘的个性化医疗：从治愈性医学到预防性医学。
Eur Respir Rev. 2017 Jan 3;26(143). doi: 10.1183/16000617.0010-2016. Print 2017 Jan.
10
Asthma-COPD overlap syndrome (ACOS) vs 'pure' COPD: a distinct phenotype?哮喘-慢性阻塞性肺疾病重叠综合征（ACOS）与“单纯”慢阻肺：不同表型？
Allergy. 2017 Jan;72(1):137-145. doi: 10.1111/all.13004. Epub 2016 Sep 27.
Zotero 插件